Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High point

E V Jensen

    Breast Cancer Research and Treatment
    |January 1, 1987
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Estrogen receptors and proliferation markers in primary and recurrent breast cancer.

    Proceedings of the National Academy of Sciences of the United States of America·2001
    Same author

    A role for estrogen receptor beta in the regulation of growth of the ventral prostate.

    Proceedings of the National Academy of Sciences of the United States of America·2001
    Same author

    Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus.

    Proceedings of the National Academy of Sciences of the United States of America·2000
    Same author

    Estrogen receptors alpha and beta in the rodent mammary gland.

    Proceedings of the National Academy of Sciences of the United States of America·2000
    Same author

    Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.

    Cancer research·1998
    Same author

    Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer.

    Proceedings of the National Academy of Sciences of the United States of America·1997
    Same journal

    Comments on: Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer.

    Breast cancer research and treatment·2026
    Same journal

    Comments on: Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy.

    Breast cancer research and treatment·2026
    Same journal

    Discrimination, spectrum, and clinical utility: ICG lymphography drainage time in axillary staging.

    Breast cancer research and treatment·2026
    Same journal

    Tumor infiltrating lymphocytes (TILs) as a predictive marker of pathological complete response (pCR) in a diverse patient population with early triple negative breast cancer (TNBC) treated with neoadjuvant real-world KEYNOTE-522 regimen.

    Breast cancer research and treatment·2026
    Same journal

    Role of individualized intervention(s) on quality of life and adherence to adjuvant endocrine therapy in premenopausal women with early-stage breast cancer: MyCHOICE study.

    Breast cancer research and treatment·2026
    Same journal

    Subjective socioeconomic status moderates the relationship between objective neighborhood disadvantage and quality of life in middle- and older-aged women with breast cancer.

    Breast cancer research and treatment·2026
    See all related articles